Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur J Immunol. 2010 Oct;40(10):2686-91. doi: 10.1002/eji.201040673.

IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Author information

  • 1INSERM U976, Saint Louis Hospital, Skin Research Center, Paris, France. jean-david.bouaziz@sls.aphp.fr

Abstract

IL-10-producing regulatory B cells have been identified in mice and shown to downregulate inflammation, making them potentially important for maintenance of tolerance. In this study, we isolated B cells from human blood and spleen, and showed that after a short period of ex vivo stimulation a number of these cells produced IL-10. The IL-10-producing B cells did not fall within a single clearly defined subpopulation, but were enriched in both the memory (CD27(+)) and the transitional (CD38(high)) B-cell compartments. Combined CpG-B+anti-Ig stimulation was the most potent IL-10 stimulus tested. B cells stimulated in this way inhibited CD4(+)CD25(-) T-cell proliferation in vitro by a partially IL-10-dependent mechanism. These findings imply that manipulating IL-10 production by human B cells could be a useful therapeutic strategy for modulating immune responses in humans.

Comment in

PMID:
20809522
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk